Ipca Laboratories Limited (IPCALAB.BO)
INR 1363.95
(4.85%)
INR 1363.95
(4.85%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 111.01 Billion INR | 28.69% |
| 2022 | 86.26 Billion INR | 13.16% |
| 2021 | 76.23 Billion INR | 25.63% |
| 2020 | 60.68 Billion INR | 15.37% |
| 2019 | 52.59 Billion INR | 15.58% |
| 2018 | 45.5 Billion INR | 10.53% |
| 2017 | 41.17 Billion INR | 3.99% |
| 2016 | 39.59 Billion INR | 1.74% |
| 2015 | 38.91 Billion INR | -5.65% |
| 2014 | 41.24 Billion INR | 28.47% |
| 2013 | 32.1 Billion INR | 19.04% |
| 2012 | 26.96 Billion INR | 15.88% |
| 2011 | 23.27 Billion INR | 21.73% |
| 2010 | 19.11 Billion INR | 18.48% |
| 2009 | 16.13 Billion INR | 17.65% |
| 2008 | 13.71 Billion INR | 18.55% |
| 2007 | 11.57 Billion INR | 27.6% |
| 2006 | 9.06 Billion INR | 23.23% |
| 2005 | 7.35 Billion INR | 7.13% |
| 2004 | 6.86 Billion INR | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | - INR | -100.0% |
| 2023 FY | 111.01 Billion INR | 28.69% |
| 2023 Q3 | - INR | -100.0% |
| 2023 Q4 | 111.01 Billion INR | 0.0% |
| 2023 Q1 | - INR | -100.0% |
| 2023 Q2 | 113.83 Billion INR | 0.0% |
| 2022 Q3 | - INR | -100.0% |
| 2022 Q4 | 86.26 Billion INR | 0.0% |
| 2022 Q1 | - INR | -100.0% |
| 2022 FY | 86.26 Billion INR | 13.16% |
| 2022 Q2 | 78.98 Billion INR | 0.0% |
| 2021 Q4 | 76.23 Billion INR | 0.0% |
| 2021 FY | 76.23 Billion INR | 25.63% |
| 2021 Q2 | 68.34 Billion INR | 0.0% |
| 2021 Q3 | - INR | -100.0% |
| 2021 Q1 | - INR | -100.0% |
| 2020 Q1 | - INR | -100.0% |
| 2020 FY | 60.68 Billion INR | 15.37% |
| 2020 Q4 | 60.68 Billion INR | 0.0% |
| 2020 Q3 | - INR | -100.0% |
| 2020 Q2 | 58.89 Billion INR | 0.0% |
| 2019 Q1 | - INR | -100.0% |
| 2019 Q4 | 52.59 Billion INR | 0.0% |
| 2019 Q3 | - INR | -100.0% |
| 2019 Q2 | 49.63 Billion INR | 0.0% |
| 2019 FY | 52.59 Billion INR | 15.58% |
| 2018 Q4 | 45.5 Billion INR | 0.0% |
| 2018 Q1 | - INR | 0.0% |
| 2018 FY | 45.5 Billion INR | 10.53% |
| 2017 FY | 41.17 Billion INR | 3.99% |
| 2016 FY | 39.59 Billion INR | 1.74% |
| 2015 FY | 38.91 Billion INR | -5.65% |
| 2014 FY | 41.24 Billion INR | 28.47% |
| 2013 FY | 32.1 Billion INR | 19.04% |
| 2012 FY | 26.96 Billion INR | 15.88% |
| 2011 FY | 23.27 Billion INR | 21.73% |
| 2010 FY | 19.11 Billion INR | 18.48% |
| 2009 FY | 16.13 Billion INR | 17.65% |
| 2008 FY | 13.71 Billion INR | 18.55% |
| 2007 FY | 11.57 Billion INR | 27.6% |
| 2006 FY | 9.06 Billion INR | 23.23% |
| 2005 FY | 7.35 Billion INR | 7.13% |
| 2004 FY | 6.86 Billion INR | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Alembic Pharmaceuticals Limited | 64.45 Billion INR | -72.231% |
| Aurobindo Pharma Limited | 450.71 Billion INR | 75.37% |
| Glenmark Life Sciences Limited | 28.5 Billion INR | -289.462% |
| Granules India Limited | 55.2 Billion INR | -101.074% |
| Indoco Remedies Limited | 21.44 Billion INR | -417.607% |
| Achyut Healthcare Limited | 309.52 Million INR | -35765.884% |
| Ajanta Pharma Limited | 46.38 Billion INR | -139.335% |
| Alkem Laboratories Limited | 155.74 Billion INR | 28.723% |
| Alpa Laboratories Limited | 1.82 Billion INR | -5978.839% |
| Brooks Laboratories Limited | 904.45 Million INR | -12174.013% |
| AstraZeneca Pharma India Limited | 10.78 Billion INR | -929.776% |
| Bajaj HealthCare Limited | 7.65 Billion INR | -1350.906% |
| Bliss GVS Pharma Limited | 12.13 Billion INR | -814.537% |
| Dr. Reddy's Laboratories Limited | 387.51 Billion INR | 71.353% |
| Eris Lifesciences Limited | 70.48 Billion INR | -57.491% |
| FDC Limited | 24.68 Billion INR | -349.792% |
| Glenmark Pharmaceuticals Limited | 143.58 Billion INR | 22.686% |
| Gufic Biosciences Limited | 10.92 Billion INR | -916.097% |
| Ind-Swift Laboratories Limited | 11.65 Billion INR | -852.813% |
| Jagsonpal Pharmaceuticals Limited | 2.17 Billion INR | -5013.959% |
| Krebs Biochemicals & Industries Limited | 1.78 Billion INR | -6130.559% |
| Lasa Supergenerics Limited | 1.5 Billion INR | -7258.239% |
| Laurus Labs Limited | 83.87 Billion INR | -32.362% |
| Lupin Limited | 239.97 Billion INR | 53.739% |
| Mankind Pharma Limited | 119.63 Billion INR | 7.205% |
| Medicamen Biotech Limited | 2.94 Billion INR | -3669.248% |
| Medico Remedies Limited | 961.95 Million INR | -11440.356% |
| Megasoft Limited | 3.65 Billion INR | -2933.968% |
| NATCO Pharma Limited | 69.06 Billion INR | -60.741% |
| Piramal Pharma Limited | 153.11 Billion INR | 27.499% |
| RPG Life Sciences Limited | 5.12 Billion INR | -2064.541% |
| Sigachi Industries Limited | 6.94 Billion INR | -1499.247% |
| Sun Pharmaceutical Industries Limited | 854.62 Billion INR | 87.01% |
| Suven Pharmaceuticals Limited | 22.54 Billion INR | -392.496% |
| Syncom Formulations (India) Limited | 4.04 Billion INR | -2643.333% |
| Unichem Laboratories Limited | 31.69 Billion INR | -250.271% |
| Wanbury Limited | 3.43 Billion INR | -3131.879% |
| Windlas Biotech Limited | 6.26 Billion INR | -1672.784% |
| ZIM Laboratories Limited | 4.46 Billion INR | -2384.496% |
| Zydus Lifesciences Limited | 292.8 Billion INR | 62.087% |
| Sun Pharma Advanced Research Company Limited | 5.15 Billion INR | -2055.421% |
| Divi's Laboratories Limited | 154.7 Billion INR | 28.24% |
| Hester Biosciences Limited | 6.62 Billion INR | -1576.052% |
| Procter & Gamble Health Limited | 7.94 Billion INR | -1297.512% |
| Amrutanjan Health Care Limited | 3.66 Billion INR | -2925.938% |
| Bal Pharma Limited | 3.2 Billion INR | -3364.938% |
| Strides Pharma Science Limited | 58.39 Billion INR | -90.098% |
| Venus Remedies Limited | 6.26 Billion INR | -1671.019% |
| Aarti Pharmalabs Limited | 25.82 Billion INR | -329.932% |
| Nectar Lifesciences Limited | 21.91 Billion INR | -406.663% |
| Shilpa Medicare Limited | 30.93 Billion INR | -258.893% |
| Aarti Drugs Limited | 24.32 Billion INR | -356.4% |
| IOL Chemicals and Pharmaceuticals Limited | 22.44 Billion INR | -394.621% |
| Suven Life Sciences Limited | 2.84 Billion INR | -3796.516% |
| Ind-Swift Limited | 6.54 Billion INR | -1596.221% |
| Valiant Laboratories Limited | 3.42 Billion INR | -3139.478% |
| J. B. Chemicals & Pharmaceuticals Limited | 39.94 Billion INR | -177.94% |
| Solara Active Pharma Sciences Limited | 23.5 Billion INR | -372.202% |
| Themis Medicare Limited | 5.66 Billion INR | -1859.915% |
| Hikal Limited | 24.87 Billion INR | -346.347% |
| Torrent Pharmaceuticals Limited | 150.61 Billion INR | 26.291% |
| Sequent Scientific Limited | 15.4 Billion INR | -620.683% |
| Novartis India Limited | 9.24 Billion INR | -1100.229% |
| Wockhardt Limited | 76.49 Billion INR | -45.134% |
| Jubilant Pharmova Limited | 115.48 Billion INR | 3.873% |
| Biofil Chemicals and Pharmaceuticals Limited | 470.82 Million INR | -23478.257% |
| Neuland Laboratories Limited | 18.32 Billion INR | -505.78% |
| Morepen Laboratories Limited | 12.93 Billion INR | -758.432% |
| Kilitch Drugs (India) Limited | 2.4 Billion INR | -4524.346% |
| Mangalam Drugs & Organics Limited | 3.33 Billion INR | -3229.476% |